The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated ... Resilia tissue bioprosthetic valves. Presented at the Heart Valve Society ...

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...

The Heart Valve Devices Market is valued at USD 12.18 Billion in 2024 and is expected to reach USD 41.88 Billion by 2035 at a ...

IRVINE, CA / ACCESS Newswire / April 23, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a ...

Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Tuesday, April 22 nd at 4:00 PM ET As part of the event, Mr. Berman will provide a corporate overview and discuss ...

Edwards Lifesciences (EW) announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary ...

Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly ...